Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Payables (2022 - 2025)

NewGenIvf (NIVF) has disclosed Payables for 4 consecutive years, with $346444.0 as the latest value for Q4 2025.

  • Quarterly Payables rose 38.46% to $346444.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $346444.0 through Dec 2025, up 38.46% year-over-year, with the annual reading at $346444.0 for FY2025, 38.46% up from the prior year.
  • Payables for Q4 2025 was $346444.0 at NewGenIvf, up from $250209.0 in the prior quarter.
  • The five-year high for Payables was $346444.0 in Q4 2025, with the low at $64077.0 in Q4 2022.
  • Average Payables over 4 years is $208339.0, with a median of $211417.5 recorded in 2023.
  • The sharpest move saw Payables soared 169.4% in 2023, then surged 38.46% in 2025.
  • Over 4 years, Payables stood at $64077.0 in 2022, then skyrocketed by 169.4% to $172626.0 in 2023, then skyrocketed by 44.94% to $250209.0 in 2024, then surged by 38.46% to $346444.0 in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $346444.0, $250209.0, and $172626.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.